Skip to content

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

Search Results

No Results

    Sorry, I don't understand. Please try again

    1. Home/
    2. Impact Ventures /
    3. Mamotest secures $3.3 million for breast cancer screening in Latin America
    A healthcare professional assists a patient during a mammogram screening.

    Mamotest secures $3.3 million for breast cancer screening in Latin America

    The company raised $3.3 million in pre-Series A funding from J&J Impact Ventures, an investment fund with J&J Foundation, Merck, Sonen Capital and venture capital firm Sky High.

    Breast cancer survival rates are significantly lower in many emerging markets than in high-income countries. Startup Mamotest want to improve early detection in the region.

    Mamotest uses AI-based diagnostics to interpret mammogram results and telehealth services to deliver results to patients. The company says it has screened 650,000 women since launching its digital health system last year; 87% of cancer-positive patients were diagnosed early enough for treatment.

    Read the full article on the ImpactAlpha website.

    J&J Impact Ventures is an investment fund within the J&J Foundation, supporting a global portfolio of early-stage companies transforming access to quality and affordable healthcare.